학술논문

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma
Document Type
Article
Source
In: European Journal of Haematology. (European Journal of Haematology, September 2006, 77(3):217-225)
Subject
Language
English
ISSN
09024441
16000609